Renaissance Technologies
BIOA

Renaissance Technologies’s BioAge Labs BIOA Stock Holding History

Renaissance Technologies’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06M Buy
165,700
+27,112
+20% +$490K 0.01% 1572
2026
Q1 		$2.42M Buy
138,588
+120,188
+653% +$2.31M ﹤0.01% 1799
2025
Q4 		$243K Sell
18,400
-124,600
-87% -$1.1M ﹤0.01% 2836
2025
Q3 		$841K Buy
143,000
+53,704
+60% +$251K ﹤0.01% 2574
2025
Q2 		$369K Buy
+89,296
New +$360K ﹤0.01% 2973

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Renaissance Technologies's BIOA Position: Q2 2026 in Review

Renaissance Technologies increased its BioAge Labs (BIOA) stake by 20% in Q2 2026, buying an estimated $490K and bringing the position to 165,700 shares worth $4.06M. The position accounts for 0.01% of the portfolio, ranked #1572.

Renaissance Technologies first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Renaissance Technologies held 165,700 shares of BioAge Labs worth $4.06M as of Q2 2026.
  • Renaissance Technologies bought 27,112 BioAge Labs shares in Q2 2026, an estimated $490K.
  • BioAge Labs made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1572 holding.
  • Renaissance Technologies first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.